Omalizumab Monoclonal Antibody from Canada
Omalizumab (Xolair) recombinant humanized monoclonal antibody binds IgE for severe asthma treatment. HTS 3002.13.0010 for unmixed monoclonal immunologicals from biotech processes. Bulk pharmaceutical grade.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide IgE binding specificity certificates
• Comply with PATENT Act for biologics exclusivity
• Avoid colloidal suspensions to stay 'unmixed'